The results showed that the tumor inhibitory efficacy of ESCs transfected with PD‐L1 nb, GM‐CSF‐peptides was significantly enhanced compared to that of ESCs alone (Figure 5a,b). The gene discussed is CSF2; the disease is neoplasm.